ABIRATERONE

ABIRATERONE was reported 41077 times

ABIRATERONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TOXIC CATARACT 5 0.7143
1 ACQUIRED APPARENT MINERALOCORTICOID EXCESS 27 0.4355
2 APPARENT MINERALOCORTICOID EXCESS 21 0.3621
3 HORMONE-DEPENDENT PROSTATE CANCER 19 0.2714
4 POLYNEUROPATHY IN MALIGNANT DISEASE 17 0.2073
5 ASCENDING FLACCID PARALYSIS 4 0.1481
6 POLYRADICULONEUROPATHY 7 0.1346
7 NEUROENDOCRINE CARCINOMA OF PROSTATE 9 0.1324
8 BRCA1 GENE MUTATION 11 0.1250
9 ACUTE BIPHENOTYPIC LEUKAEMIA 11 0.1183
10 BRCA2 GENE MUTATION 11 0.1158
11 HEREDITARY OPTIC ATROPHY 8 0.1143
12 HORMONE-REFRACTORY PROSTATE CANCER 114 0.0960
13 PROSTATE CANCER METASTATIC 283 0.0846
14 PERI-IMPLANTITIS 7 0.0787
15 PARANEOPLASTIC DERMATOMYOSITIS 5 0.0538
16 METASTASES TO NERVOUS SYSTEM 9 0.0489
17 METASTASES TO SOFT TISSUE 11 0.0425
18 PROSTATE CANCER RECURRENT 26 0.0422
19 PROSTATIC SPECIFIC ANTIGEN INCREASED 567 0.0411
20 HYPERADRENALISM 5 0.0410
21 HYPERALDOSTERONISM 14 0.0406
22 CUTANEOUS CALCIFICATION 7 0.0383
23 COLD FLASH 4 0.0345
24 SPINAL CORD INFARCTION 15 0.0340
25 MUSCULOSKELETAL TOXICITY 6 0.0323
26 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 32 0.0308
27 ACCELERATED IDIOVENTRICULAR RHYTHM 4 0.0270
28 GASTRODUODENAL ULCER 11 0.0261
29 MALIGNANT NEOPLASM OLIGOPROGRESSION 5 0.0251
30 SOFT TISSUE MASS 10 0.0216
31 PROSTATIC SPECIFIC ANTIGEN DECREASED 8 0.0212
32 METASTASES TO BLADDER 6 0.0211
33 HYDROURETER 8 0.0211
34 BLOOD CHROMOGRANIN A INCREASED 9 0.0196
35 METABOLIC ALKALOSIS 29 0.0181
36 RETROPERITONEAL LYMPHADENOPATHY 9 0.0171
37 NAIL BED INFECTION 4 0.0168
38 PRIMARY ADRENAL INSUFFICIENCY 5 0.0164
39 UROGENITAL HAEMORRHAGE 6 0.0161
40 METASTASES TO BONE 264 0.0161
41 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 6 0.0158
42 PROSTATIC HAEMORRHAGE 5 0.0157
43 OBSTRUCTIVE UROPATHY 6 0.0149
44 HOSPICE CARE 146 0.0148
45 HYPERADRENOCORTICISM 4 0.0145
46 METASTASES TO SPLEEN 6 0.0145
47 GLUCOCORTICOID DEFICIENCY 6 0.0142
48 TRANSURETHRAL PROSTATECTOMY 7 0.0140
49 ALLODYNIA 16 0.0137
50 BLADDER PERFORATION 5 0.0129
51 METASTASES TO SPINE 42 0.0125
52 SPINAL CORD COMPRESSION 47 0.0121
53 BONE CANCER METASTATIC 6 0.0113
54 RADIATION INJURY 12 0.0113
55 METASTASES TO LYMPH NODES 70 0.0104
56 BONE MARROW INFILTRATION 4 0.0103
57 THYROID HORMONES DECREASED 8 0.0100
58 PHARYNGEAL ABSCESS 5 0.0100
59 HOT FLUSH 741 0.0098
60 MYOPATHY TOXIC 6 0.0097
61 LONG QT SYNDROME 23 0.0096
62 METASTASES TO PELVIS 6 0.0095
63 URINARY TRACT OBSTRUCTION 21 0.0088
64 HYPOKALAEMIA 373 0.0081
65 SECONDARY ADRENOCORTICAL INSUFFICIENCY 12 0.0079
66 GASTROINTESTINAL EROSION 5 0.0079
67 METASTATIC SQUAMOUS CELL CARCINOMA 4 0.0078
68 URINARY BLADDER HAEMORRHAGE 16 0.0076
69 BLOOD TESTOSTERONE ABNORMAL 8 0.0072
70 HAEMORRHAGE URINARY TRACT 18 0.0071
71 CANCER PAIN 18 0.0070
72 METASTASES TO LUNG 81 0.0070
73 PLEOCYTOSIS 4 0.0069
74 ESCHAR 5 0.0068
75 HYDRONEPHROSIS 51 0.0068
76 COMA HEPATIC 5 0.0067
77 HYPERTENSIVE ENCEPHALOPATHY 4 0.0067
78 THERAPY INTERRUPTED 475 0.0066
79 RENAL TUBULAR INJURY 8 0.0066
80 MYASTHENIC SYNDROME 5 0.0065
81 ACUTE CORONARY SYNDROME 53 0.0064
82 RHABDOMYOLYSIS 266 0.0064
83 BONE LESION 23 0.0064
84 URETERIC STENOSIS 5 0.0062
85 PYELONEPHRITIS ACUTE 12 0.0061
86 SYSTEMIC INFECTION 10 0.0060
87 GASTROENTERITIS NOROVIRUS 8 0.0060
88 INFECTED BITE 5 0.0059
89 UROSEPSIS 54 0.0058
90 PROSTATIC OPERATION 7 0.0058
91 FANCONI SYNDROME ACQUIRED 10 0.0057
92 ANAEMIA OF CHRONIC DISEASE 5 0.0055
93 DISEASE PROGRESSION 608 0.0051
94 ACQUIRED HAEMOPHILIA 5 0.0050
95 PROSTATE CANCER 395 0.0049
96 PATHOLOGICAL FRACTURE 24 0.0047
97 ABDOMINAL LYMPHADENOPATHY 4 0.0046
98 PARAPARESIS 8 0.0045
99 TORSADE DE POINTES 35 0.0045
100 OPHTHALMIC HERPES ZOSTER 8 0.0044
101 HEPATOTOXICITY 97 0.0044
102 HAEMOCHROMATOSIS 4 0.0043
103 METASTASES TO LIVER 76 0.0043
104 HAEMATURIA 147 0.0043
105 BLADDER OPERATION 5 0.0043
106 METASTASIS 30 0.0042
107 METASTATIC NEOPLASM 18 0.0042
108 EMBOLISM ARTERIAL 5 0.0042
109 NOROVIRUS INFECTION 6 0.0042
110 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
111 BLOOD POTASSIUM ABNORMAL 11 0.0041
112 DRUG-INDUCED LIVER INJURY 129 0.0041
113 MALIGNANT NEOPLASM PROGRESSION 416 0.0041
114 LARGE INTESTINAL OBSTRUCTION 9 0.0040
115 AORTIC VALVE REPLACEMENT 5 0.0040
116 BRAIN FOG 62 0.0040
117 SEROMA 5 0.0039
118 BLOOD POTASSIUM DECREASED 118 0.0039
119 TRANSITIONAL CELL CARCINOMA 5 0.0039
120 ACQUIRED GENE MUTATION 5 0.0038
121 OSTEOSCLEROSIS 6 0.0038
122 TUMOUR PAIN 5 0.0038
123 NOCTURIA 46 0.0038
124 RADIOTHERAPY 7 0.0037
125 OSTEOPOROTIC FRACTURE 7 0.0037
126 NAIL GROWTH ABNORMAL 4 0.0036
127 ADRENOCORTICAL INSUFFICIENCY ACUTE 7 0.0036
128 BLADDER NEOPLASM 6 0.0035
129 NON-CARDIAC CHEST PAIN 11 0.0035
130 BLOOD ALKALINE PHOSPHATASE INCREASED 86 0.0035
131 OSTEOCHONDROSIS 4 0.0034
132 ADRENAL INSUFFICIENCY 40 0.0033
133 HAEMATOLOGICAL INFECTION 8 0.0033
134 BLOOD TESTOSTERONE INCREASED 7 0.0033
135 JAW FRACTURE 7 0.0032
136 CATHETER PLACEMENT 6 0.0032
137 LUNG CONSOLIDATION 9 0.0032
138 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 4 0.0032
139 CHEMOTHERAPY 12 0.0032
140 SEDATION COMPLICATION 8 0.0031
141 FEMORAL NECK FRACTURE 16 0.0031
142 IMMUNE-MEDIATED MYOCARDITIS 5 0.0031
143 FAILURE TO THRIVE 16 0.0031
144 CHOLECYSTITIS ACUTE 17 0.0030
145 CRANIOCEREBRAL INJURY 9 0.0030
146 CALCULUS BLADDER 4 0.0029
147 URINE FLOW DECREASED 7 0.0029
148 CYTOMEGALOVIRUS VIRAEMIA 13 0.0029
149 THERAPY CESSATION 149 0.0029
150 LYMPHOEDEMA 20 0.0029
151 ALVEOLITIS 4 0.0028
152 PROSTATE CANCER STAGE IV 10 0.0028
153 ABSCESS INTESTINAL 6 0.0028
154 MUSCLE ATROPHY 35 0.0028
155 BONE CANCER 12 0.0028
156 ESSENTIAL HYPERTENSION 5 0.0027
157 ACUTE ABDOMEN 4 0.0027
158 URINARY RETENTION 91 0.0027
159 OSTEONECROSIS OF JAW 66 0.0027
160 SPINAL COMPRESSION FRACTURE 22 0.0027
161 INFECTED SKIN ULCER 5 0.0026
162 HYPERVOLAEMIA 13 0.0026
163 PROSTATITIS 8 0.0026
164 DISEASE COMPLICATION 12 0.0026
165 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
166 CORONARY ARTERY STENOSIS 13 0.0026
167 RIB FRACTURE 53 0.0026
168 DUODENAL ULCER 18 0.0025
169 BLOOD MAGNESIUM DECREASED 22 0.0025
170 ACUTE KIDNEY INJURY 384 0.0025
171 HYPOCALCAEMIA 47 0.0025
172 BLOOD PHOSPHORUS DECREASED 9 0.0025
173 IMMUNE-MEDIATED HEPATITIS 5 0.0024
174 OSTEOLYSIS 5 0.0024
175 THERAPY CHANGE 24 0.0024
176 HYPOPHOSPHATAEMIA 18 0.0024
177 HYPERAESTHESIA 20 0.0024
178 QUADRIPLEGIA 5 0.0024
179 CHEST INJURY 5 0.0024
180 LIVER FUNCTION TEST ABNORMAL 70 0.0024
181 NEPHROPATHY TOXIC 27 0.0024
182 BLOOD URINE PRESENT 45 0.0024
183 CLAVICLE FRACTURE 9 0.0023
184 ATRIAL FIBRILLATION 228 0.0023
185 ACUTE MYOCARDIAL INFARCTION 69 0.0023
186 DRUG RESISTANCE 60 0.0023
187 ANAEMIA 444 0.0023
188 MUSCULOSKELETAL CHEST PAIN 36 0.0023
189 HAEMATOTOXICITY 22 0.0023
190 EMERGENCY CARE 7 0.0023
191 HYPERTRANSAMINASAEMIA 16 0.0023
192 DRUG INTERACTION 364 0.0023
193 PROSTATOMEGALY 9 0.0023
194 ALANINE AMINOTRANSFERASE INCREASED 139 0.0023
195 THERAPY PARTIAL RESPONDER 35 0.0022
196 TERMINAL STATE 15 0.0022
197 TESTICULAR PAIN 7 0.0022
198 OESOPHAGITIS 24 0.0022
199 BLOOD TESTOSTERONE DECREASED 15 0.0022
200 TYPE IV HYPERSENSITIVITY REACTION 6 0.0022
201 LIVER FUNCTION TEST INCREASED 47 0.0022
202 ODYNOPHAGIA 13 0.0022
203 POLLAKIURIA 90 0.0022
204 RENAL TUBULAR NECROSIS 21 0.0021
205 ADENOCARCINOMA OF COLON 4 0.0021
206 HYPERBILIRUBINAEMIA 22 0.0021
207 BLOOD BILIRUBIN INCREASED 57 0.0021
208 PNEUMATOSIS INTESTINALIS 6 0.0021
209 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
210 LYMPHADENOPATHY MEDIASTINAL 4 0.0021
211 POLYNEUROPATHY 25 0.0021
212 GASTROINTESTINAL TOXICITY 10 0.0021
213 PARAPLEGIA 6 0.0021
214 DERMATITIS ALLERGIC 26 0.0021
215 WOUND SECRETION 8 0.0020
216 CERVICAL VERTEBRAL FRACTURE 7 0.0020
217 THORACIC VERTEBRAL FRACTURE 6 0.0020
218 HEPATITIS FULMINANT 6 0.0020
219 MICTURITION URGENCY 23 0.0020
220 DYSURIA 74 0.0020
221 NONSPECIFIC REACTION 11 0.0020
222 EMBOLIC STROKE 7 0.0020
223 DEVICE RELATED SEPSIS 4 0.0020
224 TRANSAMINASES INCREASED 44 0.0020
225 URINARY TRACT INFECTION 337 0.0020
226 APPENDICITIS PERFORATED 5 0.0020
227 HYPERGLYCAEMIA 71 0.0019
228 ASPARTATE AMINOTRANSFERASE INCREASED 103 0.0019
229 SPINAL STENOSIS 8 0.0019
230 GROIN PAIN 17 0.0019
231 CATHETER SITE PAIN 5 0.0019
232 HERNIA REPAIR 5 0.0019
233 FOREIGN BODY IN THROAT 6 0.0019
234 BONE PAIN 111 0.0019
235 BLADDER PAIN 6 0.0019
236 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
237 NIGHT SWEATS 60 0.0019
238 PRODUCT SIZE ISSUE 10 0.0019
239 MYOPATHY 16 0.0019
240 POLYURIA 15 0.0018
241 COLONOSCOPY 4 0.0018
242 THROMBOCYTOPENIA 203 0.0018
243 TRANSIENT ISCHAEMIC ATTACK 61 0.0018
244 HEPATIC CYTOLYSIS 23 0.0018
245 CARDIAC FAILURE ACUTE 12 0.0018
246 NEPHRITIS 6 0.0018
247 CARDIOTOXICITY 16 0.0018
248 ADENOCARCINOMA 4 0.0018
249 SEPSIS 198 0.0018
250 DEATH 1523 0.0018
251 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0018
252 AUTOIMMUNE HAEMOLYTIC ANAEMIA 6 0.0017
253 CARDIAC OPERATION 15 0.0017
254 HOSPITALISATION 268 0.0017
255 QUALITY OF LIFE DECREASED 23 0.0017
256 DISCOURAGEMENT 4 0.0017
257 VENTRICULAR FIBRILLATION 19 0.0017
258 HYPERTRIGLYCERIDAEMIA 10 0.0017
259 INGROWING NAIL 4 0.0017
260 SKIN ABRASION 8 0.0017
261 AORTIC DISSECTION 7 0.0017
262 HEPATIC ENZYME INCREASED 115 0.0017
263 CARDIAC FAILURE 135 0.0017
264 CREPITATIONS 5 0.0017
265 HYPERTENSION 353 0.0017
266 HUMERUS FRACTURE 8 0.0017
267 EMBOLISM VENOUS 5 0.0016
268 ELECTROLYTE IMBALANCE 19 0.0016
269 VENTRICULAR TACHYCARDIA 27 0.0016
270 ISCHAEMIC STROKE 29 0.0016
271 URINARY INCONTINENCE 48 0.0016
272 STENT PLACEMENT 13 0.0016
273 ASTHENIA 606 0.0016
274 BRAIN ABSCESS 4 0.0016
275 CORONARY ARTERIAL STENT INSERTION 8 0.0016
276 POLYMYALGIA RHEUMATICA 5 0.0016
277 LOSS OF THERAPEUTIC RESPONSE 5 0.0016
278 NOCARDIOSIS 4 0.0016
279 URINARY TRACT DISORDER 7 0.0016
280 PHYSICAL DECONDITIONING 4 0.0016
281 METABOLIC DISORDER 9 0.0015
282 HAEMORRHAGIC STROKE 12 0.0015
283 FRACTURE 29 0.0015
284 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
285 SARS-COV-2 TEST POSITIVE 20 0.0015
286 GENERAL PHYSICAL HEALTH DETERIORATION 175 0.0015
287 CARDIAC PACEMAKER INSERTION 9 0.0015
288 MYASTHENIA GRAVIS 12 0.0015
289 SYNCOPE 148 0.0015
290 FATIGUE 1149 0.0015
291 LEG AMPUTATION 6 0.0015
292 GENERALISED OEDEMA 18 0.0015
293 INTERNATIONAL NORMALISED RATIO ABNORMAL 5 0.0015
294 IMMUNE-MEDIATED MYOSITIS 4 0.0014
295 MICTURITION DISORDER 5 0.0014
296 COVID-19 PNEUMONIA 17 0.0014
297 AORTIC STENOSIS 5 0.0014
298 OEDEMA PERIPHERAL 175 0.0014
299 LIPASE INCREASED 11 0.0014
300 VITAMIN D DEFICIENCY 14 0.0014
301 PLEURAL EFFUSION 87 0.0014
302 GASTRIC ULCER 27 0.0014
303 FULL BLOOD COUNT ABNORMAL 15 0.0014
304 ATYPICAL FEMUR FRACTURE 4 0.0014
305 NEOPLASM PROGRESSION 49 0.0014
306 HEPATIC ENZYME ABNORMAL 7 0.0014
307 INTERCEPTED PRODUCT STORAGE ERROR 5 0.0014
308 HAEMOGLOBIN ABNORMAL 9 0.0014
309 RECTAL HAEMORRHAGE 60 0.0014
310 PRODUCT USE COMPLAINT 22 0.0014
311 EXERCISE TOLERANCE DECREASED 8 0.0014
312 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
313 FLANK PAIN 13 0.0014
314 SKIN LACERATION 15 0.0014
315 FALL 459 0.0014
316 PULMONARY EMBOLISM 131 0.0014
317 MUSCULAR WEAKNESS 156 0.0014
318 GASTRITIS 36 0.0014
319 DEVICE RELATED INFECTION 21 0.0014
320 HYPERTENSIVE CRISIS 15 0.0013
321 HIP FRACTURE 43 0.0013
322 METABOLIC ENCEPHALOPATHY 4 0.0013
323 LYMPHADENOPATHY 47 0.0013
324 CEREBROVASCULAR DISORDER 4 0.0013
325 CATHETER SITE INFECTION 5 0.0013
326 FACE INJURY 5 0.0013
327 HEPATIC FUNCTION ABNORMAL 49 0.0013
328 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
329 GINGIVITIS 7 0.0013
330 BLOOD POTASSIUM INCREASED 21 0.0013
331 HIP SURGERY 7 0.0013
332 HYPOMAGNESAEMIA 18 0.0013
333 REHABILITATION THERAPY 5 0.0013
334 EMPHYSEMA 13 0.0013
335 ERYTHEMA MULTIFORME 12 0.0013
336 HYPOALBUMINAEMIA 10 0.0013
337 CONSTIPATION 279 0.0013
338 OEDEMA 69 0.0013
339 HEPATOCELLULAR INJURY 18 0.0013
340 DEHYDRATION 169 0.0013
341 PULSE ABSENT 6 0.0013
342 ATRIAL FLUTTER 10 0.0013
343 PANCREATITIS ACUTE 28 0.0012
344 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
345 DIZZINESS POSTURAL 12 0.0012
346 MYOSITIS 11 0.0012
347 SPINAL FRACTURE 24 0.0012
348 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
349 INCREASED TENDENCY TO BRUISE 11 0.0012
350 SPINAL PAIN 14 0.0012
351 ABSCESS 19 0.0012
352 NEUROPATHY PERIPHERAL 113 0.0012
353 PRODUCT DISTRIBUTION ISSUE 11 0.0012
354 CATARACT OPERATION 7 0.0012
355 FLUID RETENTION 60 0.0012
356 NEPHROLITHIASIS 54 0.0012
357 DECREASED APPETITE 273 0.0012
358 PNEUMONITIS 32 0.0012
359 HEPATIC PAIN 5 0.0012
360 ARTERIOSCLEROSIS 11 0.0012
361 CEREBRAL ISCHAEMIA 6 0.0012
362 LOWER RESPIRATORY TRACT INFECTION 53 0.0012
363 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
364 HEPATIC LESION 5 0.0012
365 BLOOD CALCIUM DECREASED 13 0.0012
366 HYPOPNOEA 4 0.0012
367 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
368 BLOOD LACTIC ACID INCREASED 6 0.0011
369 JOINT DISLOCATION 12 0.0011
370 SUDDEN DEATH 12 0.0011
371 RENAL PAIN 12 0.0011
372 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
373 CARDIAC FAILURE CONGESTIVE 90 0.0011
374 ILEUS PARALYTIC 5 0.0011
375 COMPRESSION FRACTURE 6 0.0011
376 BLOOD PRESSURE ABNORMAL 22 0.0011
377 VASCULAR DEVICE INFECTION 5 0.0011
378 PULMONARY THROMBOSIS 12 0.0011
379 FOOD INTOLERANCE 4 0.0011
380 ACUTE RESPIRATORY FAILURE 21 0.0011
381 BACK PAIN 252 0.0011
382 EMBOLISM 9 0.0011
383 RASH MACULO-PAPULAR 24 0.0011
384 PULMONARY MASS 16 0.0011
385 PERFORMANCE STATUS DECREASED 5 0.0011
386 HAEMOGLOBIN DECREASED 110 0.0011
387 KIDNEY INFECTION 21 0.0011
388 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
389 PRESYNCOPE 26 0.0011
390 HYPOPHAGIA 27 0.0011
391 HYPERKALAEMIA 37 0.0011
392 AORTIC ANEURYSM 8 0.0011
393 INTERNAL HAEMORRHAGE 12 0.0010
394 ACIDOSIS 8 0.0010
395 SKIN ATROPHY 6 0.0010
396 PNEUMONIA 337 0.0010
397 FAECAL INCONTINENCE 5 0.0010
398 INCONTINENCE 11 0.0010
399 MUSCLE STRAIN 9 0.0010
400 DYSPNOEA EXERTIONAL 39 0.0010
401 ULCER HAEMORRHAGE 7 0.0010
402 BONE MARROW FAILURE 21 0.0010
403 MUSCLE RUPTURE 4 0.0010
404 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29 0.0010
405 CONTUSION 98 0.0010
406 DEEP VEIN THROMBOSIS 66 0.0010
407 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
408 LIGAMENT SPRAIN 10 0.0010
409 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
410 FORMICATION 7 0.0010
411 HYPERNATRAEMIA 5 0.0010
412 HYPERPHAGIA 4 0.0010
413 OBSTRUCTION 4 0.0010
414 LOSS OF LIBIDO 9 0.0010
415 LEUKOPENIA 50 0.0010
416 FLUID INTAKE REDUCED 5 0.0010
417 TOOTH FRACTURE 11 0.0010
418 LETHARGY 57 0.0010
419 GALLBLADDER OPERATION 4 0.0010
420 POST PROCEDURAL INFECTION 8 0.0010
421 CEREBRAL HAEMORRHAGE 35 0.0010
422 SMALL INTESTINAL OBSTRUCTION 12 0.0010
423 HYPERURICAEMIA 4 0.0010
424 TENDON RUPTURE 12 0.0010
425 MYOCARDIAL ISCHAEMIA 11 0.0010
426 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
427 NEUTROPENIA 130 0.0010
428 RENAL IMPAIRMENT 80 0.0010
429 ACUTE HEPATIC FAILURE 13 0.0010
430 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
431 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
432 MUSCLE FATIGUE 4 0.0009
433 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
434 CYSTITIS 30 0.0009
435 PULMONARY OEDEMA 42 0.0009
436 GAIT INABILITY 31 0.0009
437 PYELONEPHRITIS 8 0.0009
438 HYPONATRAEMIA 52 0.0009
439 BLOOD PRESSURE INCREASED 140 0.0009
440 HIP ARTHROPLASTY 14 0.0009
441 BOWEL MOVEMENT IRREGULARITY 7 0.0009
442 FAECALOMA 5 0.0009
443 ORAL CANDIDIASIS 12 0.0009
444 WALKING AID USER 6 0.0009
445 RED BLOOD CELL COUNT DECREASED 26 0.0009
446 INTESTINAL ISCHAEMIA 5 0.0009
447 HYPOGLYCAEMIA 44 0.0009
448 DRUG LEVEL INCREASED 15 0.0009
449 ATRIOVENTRICULAR BLOCK 7 0.0009
450 CONCUSSION 7 0.0009
451 BLOOD CREATINE INCREASED 4 0.0009
452 DIVERTICULITIS 25 0.0009
453 MALIGNANT MELANOMA 12 0.0009
454 COVID-19 156 0.0009
455 TASTE DISORDER 18 0.0009
456 ARRHYTHMIA 42 0.0009
457 CHROMATURIA 20 0.0009
458 SKIN TOXICITY 5 0.0009
459 PELVIC PAIN 16 0.0009
460 ABNORMAL LOSS OF WEIGHT 6 0.0009
461 BONE DISORDER 16 0.0009
462 INTENTIONAL DOSE OMISSION 25 0.0009
463 BLOOD DISORDER 7 0.0009
464 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
465 NERVE COMPRESSION 8 0.0009
466 ENTEROCOLITIS 5 0.0009
467 NEUTROPHIL COUNT DECREASED 35 0.0009
468 PERIPHERAL SWELLING 132 0.0009
469 SECOND PRIMARY MALIGNANCY 7 0.0008
470 HEART RATE IRREGULAR 19 0.0008
471 ANGINA PECTORIS 24 0.0008
472 GOUT 15 0.0008
473 POST PROCEDURAL COMPLICATION 16 0.0008
474 CONFUSIONAL STATE 134 0.0008
475 HYPERCHOLESTEROLAEMIA 8 0.0008
476 SINUS BRADYCARDIA 8 0.0008
477 BACK INJURY 9 0.0008
478 PNEUMOTHORAX 13 0.0008
479 ANURIA 7 0.0008
480 ARTHROPOD BITE 6 0.0008
481 HYPERHIDROSIS 104 0.0008
482 ORGANISING PNEUMONIA 4 0.0008
483 DELIRIUM 28 0.0008
484 MALNUTRITION 9 0.0008
485 UPPER LIMB FRACTURE 16 0.0008
486 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
487 TUMOUR LYSIS SYNDROME 7 0.0008
488 ADVERSE EVENT 73 0.0008
489 COLITIS 30 0.0008
490 HEAD INJURY 25 0.0008
491 SURGERY 46 0.0008
492 MOOD SWINGS 25 0.0008
493 BODY TEMPERATURE INCREASED 16 0.0008
494 PROCEDURAL COMPLICATION 6 0.0008
495 ENDOCARDITIS 4 0.0008
496 MYELOSUPPRESSION 28 0.0008
497 LIMB INJURY 21 0.0008
498 ACUTE MYELOID LEUKAEMIA 12 0.0008
499 ANGINA UNSTABLE 5 0.0008
500 SUBDURAL HAEMATOMA 11 0.0008
501 HYPERSOMNIA 22 0.0008
502 NEOPLASM MALIGNANT 51 0.0008
503 BALANCE DISORDER 66 0.0008
504 TRANSFUSION 8 0.0008
505 MYOCARDIAL INFARCTION 133 0.0008
506 BLOOD IRON DECREASED 9 0.0008
507 MENTAL STATUS CHANGES 21 0.0008
508 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
509 AGRANULOCYTOSIS 14 0.0008
510 DEMENTIA 21 0.0008
511 CEREBROVASCULAR ACCIDENT 127 0.0007
512 FOOD POISONING 4 0.0007
513 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
514 FEMUR FRACTURE 23 0.0007
515 BRONCHIECTASIS 5 0.0007
516 RESPIRATORY FAILURE 54 0.0007
517 ERECTILE DYSFUNCTION 19 0.0007
518 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
519 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
520 HAEMORRHAGE INTRACRANIAL 11 0.0007
521 PERICARDIAL EFFUSION 17 0.0007
522 THROMBOSIS 59 0.0007
523 HYPERCALCAEMIA 9 0.0007
524 MUSCULOSKELETAL PAIN 38 0.0007
525 FEBRILE NEUTROPENIA 48 0.0007
526 DYSSTASIA 21 0.0007
527 LEUKOCYTOSIS 13 0.0007
528 CHEST PAIN 133 0.0007
529 ROAD TRAFFIC ACCIDENT 30 0.0007
530 ANGIOPATHY 4 0.0007
531 ACUTE PULMONARY OEDEMA 4 0.0007
532 INTESTINAL PERFORATION 8 0.0007
533 FACIAL PARALYSIS 6 0.0007
534 LOSS OF CONSCIOUSNESS 90 0.0007
535 SCAB 8 0.0007
536 MUSCULOSKELETAL DISCOMFORT 12 0.0007
537 BACTERIAL INFECTION 13 0.0007
538 SKIN CANCER 15 0.0007
539 HEPATIC FAILURE 21 0.0007
540 CORONARY ARTERY BYPASS 4 0.0007
541 GASTRIC HAEMORRHAGE 8 0.0007
542 THERAPY NON-RESPONDER 31 0.0007
543 SEPTIC SHOCK 30 0.0007
544 FAECES SOFT 5 0.0007
545 BLOOD CALCIUM INCREASED 6 0.0007
546 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
547 LYMPHOCYTE COUNT DECREASED 12 0.0007
548 BRADYKINESIA 4 0.0007
549 VENTRICULAR EXTRASYSTOLES 7 0.0007
550 ERUCTATION 13 0.0007
551 CHOLECYSTITIS 8 0.0007
552 WEIGHT FLUCTUATION 7 0.0007
553 JAUNDICE 18 0.0007
554 CHOKING 13 0.0007
555 DIZZINESS 332 0.0007
556 GASTROENTERITIS VIRAL 12 0.0007
557 HEPATITIS CHOLESTATIC 4 0.0007
558 INTESTINAL OBSTRUCTION 25 0.0007
559 PEMPHIGOID 5 0.0007
560 PANCYTOPENIA 37 0.0007
561 CORONARY ARTERY DISEASE 20 0.0007
562 BLOOD UREA INCREASED 11 0.0007
563 METABOLIC ACIDOSIS 21 0.0007
564 OSTEOPOROSIS 27 0.0007
565 RENAL FAILURE 87 0.0007
566 RESPIRATORY DEPRESSION 8 0.0007
567 RESPIRATORY TRACT INFECTION 17 0.0007
568 RETINAL DETACHMENT 6 0.0007
569 SPINAL OPERATION 8 0.0006
570 FEELING COLD 18 0.0006
571 OLIGURIA 4 0.0006
572 PELVIC FRACTURE 5 0.0006
573 CARDIAC ARREST 53 0.0006
574 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
575 BLOOD TEST ABNORMAL 9 0.0006
576 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
577 DIARRHOEA 411 0.0006
578 BLOOD SODIUM DECREASED 12 0.0006
579 LYMPHOPENIA 9 0.0006
580 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
581 CELLULITIS 32 0.0006
582 LIVER DISORDER 28 0.0006
583 HYPOTENSION 126 0.0006
584 SCIATICA 10 0.0006
585 BLOOD GLUCOSE INCREASED 118 0.0006
586 ENTERITIS 4 0.0006
587 GASTROINTESTINAL HAEMORRHAGE 52 0.0006
588 LOCALISED INFECTION 15 0.0006
589 CARDIAC FLUTTER 4 0.0006
590 INCOHERENT 4 0.0006
591 EMOTIONAL DISORDER 19 0.0006
592 HAEMATOCHEZIA 34 0.0006
593 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
594 HAEMORRHOIDS 12 0.0006
595 DECUBITUS ULCER 5 0.0006
596 BLOOD CREATININE INCREASED 40 0.0006
597 LIVER INJURY 15 0.0006
598 NEOPLASM 7 0.0006
599 ESCHERICHIA INFECTION 5 0.0006
600 CORONAVIRUS INFECTION 4 0.0006
601 BLADDER DISORDER 6 0.0006
602 APPETITE DISORDER 4 0.0006
603 INFECTION 87 0.0006
604 FULL BLOOD COUNT DECREASED 12 0.0006
605 PLATELET COUNT DECREASED 63 0.0006
606 MELAENA 13 0.0006
607 DYSPHAGIA 56 0.0006
608 BACTERAEMIA 7 0.0006
609 RENAL FAILURE ACUTE 25 0.0006
610 ABDOMINAL PAIN 136 0.0006
611 ARTHRALGIA 242 0.0006
612 DISORIENTATION 23 0.0006
613 WEIGHT DECREASED 162 0.0006
614 LUNG INFECTION 9 0.0006
615 ADVERSE DRUG REACTION 52 0.0006
616 ENCEPHALITIS 4 0.0006
617 LARGE INTESTINE POLYP 4 0.0006
618 COORDINATION ABNORMAL 8 0.0006
619 INFUSION RELATED REACTION 38 0.0006
620 CYTOPENIA 7 0.0006
621 MOBILITY DECREASED 41 0.0006
622 TREATMENT FAILURE 47 0.0006
623 DYSPNOEA 321 0.0006
624 IMMUNOSUPPRESSION 5 0.0006
625 CARDIAC DISORDER 53 0.0006
626 HAND FRACTURE 4 0.0006
627 JOINT INJURY 12 0.0006
628 PARALYSIS 8 0.0006
629 RENAL DISORDER 26 0.0006
630 FAECES DISCOLOURED 12 0.0006
631 MYELODYSPLASTIC SYNDROME 8 0.0006
632 INCORRECT DOSE ADMINISTERED 126 0.0006
633 CARDIOVASCULAR DISORDER 14 0.0006
634 BLOOD GLUCOSE FLUCTUATION 6 0.0005
635 CARDIOMYOPATHY 8 0.0005
636 DIABETIC KETOACIDOSIS 13 0.0005
637 HEART RATE DECREASED 19 0.0005
638 COAGULOPATHY 9 0.0005
639 PERSONALITY CHANGE 5 0.0005
640 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 28 0.0005
641 VOMITING 252 0.0005
642 EPISTAXIS 40 0.0005
643 BEDRIDDEN 7 0.0005
644 TOOTH INFECTION 7 0.0005
645 LUNG DISORDER 26 0.0005
646 DIABETES MELLITUS 40 0.0005
647 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
648 AGEUSIA 13 0.0005
649 DYSPEPSIA 51 0.0005
650 LYMPHOMA 8 0.0005
651 ATELECTASIS 5 0.0005
652 ANKLE FRACTURE 8 0.0005
653 POST PROCEDURAL HAEMORRHAGE 6 0.0005
654 EJECTION FRACTION DECREASED 8 0.0005
655 INSOMNIA 137 0.0005
656 HYPOXIA 18 0.0005
657 HEPATITIS 13 0.0005
658 PYREXIA 174 0.0005
659 ACCIDENT 6 0.0005
660 HAEMOPTYSIS 14 0.0005
661 MUSCLE RIGIDITY 6 0.0005
662 HYPOTONIA 5 0.0005
663 PAIN IN EXTREMITY 147 0.0005
664 TOOTHACHE 9 0.0005
665 OSTEOMYELITIS 9 0.0005
666 SKIN REACTION 7 0.0005
667 INTERSTITIAL LUNG DISEASE 24 0.0005
668 GASTRIC DISORDER 17 0.0005
669 SEASONAL ALLERGY 7 0.0005
670 MUSCLE DISORDER 4 0.0005
671 FEEDING DISORDER 10 0.0005
672 COGNITIVE DISORDER 23 0.0005
673 GAIT DISTURBANCE 94 0.0005
674 TOOTH ABSCESS 5 0.0005
675 SUBARACHNOID HAEMORRHAGE 5 0.0005
676 BRADYCARDIA 26 0.0005
677 JOINT SWELLING 59 0.0005
678 CHOLELITHIASIS 16 0.0005
679 CARDIOGENIC SHOCK 7 0.0005
680 GYNAECOMASTIA 15 0.0005
681 ILEUS 6 0.0005
682 TOOTH EXTRACTION 6 0.0005
683 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
684 MIDDLE INSOMNIA 9 0.0005
685 TOXICITY TO VARIOUS AGENTS 81 0.0005
686 NAUSEA 380 0.0005
687 GASTROENTERITIS 7 0.0005
688 PHOTOPHOBIA 9 0.0005
689 CHILLS 56 0.0005
690 MYALGIA 81 0.0005
691 VERTIGO 29 0.0005
692 CHRONIC KIDNEY DISEASE 36 0.0005
693 INCREASED APPETITE 9 0.0005
694 DRY MOUTH 38 0.0005
695 BLOOD PRESSURE DECREASED 31 0.0005
696 UNRESPONSIVE TO STIMULI 12 0.0005
697 RESTLESSNESS 17 0.0005
698 CARDIAC MURMUR 4 0.0005
699 OSTEOPENIA 7 0.0005
700 INSURANCE ISSUE 7 0.0005
701 GRIP STRENGTH DECREASED 4 0.0005
702 CARDIO-RESPIRATORY ARREST 19 0.0005
703 HAEMATOCRIT DECREASED 9 0.0005
704 ABDOMINAL DISCOMFORT 76 0.0005
705 ADVERSE REACTION 6 0.0005
706 DYSARTHRIA 17 0.0005
707 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
708 DRUG ERUPTION 8 0.0005
709 CEREBRAL INFARCTION 11 0.0004
710 HAEMORRHAGE 47 0.0004
711 NECK PAIN 25 0.0004
712 HAEMOLYTIC ANAEMIA 4 0.0004
713 PRODUCT ADMINISTRATION ERROR 9 0.0004
714 ANAL INCONTINENCE 4 0.0004
715 FREQUENT BOWEL MOVEMENTS 12 0.0004
716 OROPHARYNGEAL DISCOMFORT 4 0.0004
717 ASCITES 13 0.0004
718 SEIZURE 51 0.0004
719 TACHYPNOEA 6 0.0004
720 FLATULENCE 25 0.0004
721 FEELING HOT 27 0.0004
722 ULCER 7 0.0004
723 PRODUCTIVE COUGH 21 0.0004
724 WEIGHT INCREASED 98 0.0004
725 MYOCARDITIS 5 0.0004
726 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
727 PNEUMONIA BACTERIAL 4 0.0004
728 GASTROINTESTINAL DISORDER 39 0.0004
729 PRODUCT DOSE OMISSION ISSUE 128 0.0004
730 HERPES ZOSTER 25 0.0004
731 RESPIRATORY DISTRESS 12 0.0004
732 PULMONARY HYPERTENSION 9 0.0004
733 EYELID OEDEMA 5 0.0004
734 MASS 6 0.0004
735 STOMATITIS 26 0.0004
736 APPENDICITIS 4 0.0004
737 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
738 SEXUAL DYSFUNCTION 5 0.0004
739 DEVICE OCCLUSION 6 0.0004
740 PAIN IN JAW 12 0.0004
741 EATING DISORDER 9 0.0004
742 FOOT FRACTURE 8 0.0004
743 ABDOMINAL DISTENSION 44 0.0004
744 PROTEINURIA 8 0.0004
745 MUCOSAL INFLAMMATION 11 0.0004
746 HYPERLIPIDAEMIA 5 0.0004
747 PALPITATIONS 49 0.0004
748 WRIST FRACTURE 5 0.0004
749 PRODUCT SUBSTITUTION ISSUE 24 0.0004
750 PAIN 255 0.0004
751 FACE OEDEMA 7 0.0004
752 ABDOMINAL PAIN UPPER 85 0.0004
753 INFLUENZA 46 0.0004
754 CIRCULATORY COLLAPSE 7 0.0004
755 SLEEP DISORDER 29 0.0004
756 PHARYNGEAL SWELLING 4 0.0004
757 ENCEPHALOPATHY 10 0.0004
758 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
759 OFF LABEL USE 353 0.0004
760 ORTHOSTATIC HYPOTENSION 7 0.0004
761 PNEUMONIA ASPIRATION 10 0.0004
762 RESPIRATORY ARREST 11 0.0004
763 LACRIMATION INCREASED 12 0.0004
764 WHITE BLOOD CELL COUNT DECREASED 43 0.0004
765 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
766 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
767 ABDOMINAL PAIN LOWER 10 0.0004
768 DRUG LEVEL DECREASED 4 0.0004
769 GALLBLADDER DISORDER 7 0.0004
770 THIRST 7 0.0004
771 PRODUCT USE IN UNAPPROVED INDICATION 96 0.0004
772 MUSCLE SPASMS 71 0.0004
773 HIATUS HERNIA 5 0.0004
774 TYPE 2 DIABETES MELLITUS 13 0.0004
775 BLOOD CHOLESTEROL INCREASED 18 0.0004
776 HAEMATOMA 10 0.0004
777 RESTLESS LEGS SYNDROME 7 0.0004
778 DRUG INEFFECTIVE 505 0.0004
779 PARAESTHESIA 60 0.0004
780 MOUTH ULCERATION 8 0.0004
781 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
782 BLOOD GLUCOSE ABNORMAL 7 0.0004
783 PANCREATITIS 20 0.0004
784 POOR QUALITY SLEEP 8 0.0004
785 MEMORY IMPAIRMENT 51 0.0004
786 DECREASED ACTIVITY 4 0.0004
787 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
788 BACK DISORDER 6 0.0004
789 MUSCULOSKELETAL DISORDER 7 0.0004
790 SOMNOLENCE 74 0.0004
791 HYPOAESTHESIA 55 0.0004
792 PRODUCT DISPENSING ERROR 8 0.0004
793 MOOD ALTERED 10 0.0004
794 GINGIVAL BLEEDING 5 0.0004
795 PULMONARY FIBROSIS 7 0.0004
796 CORONARY ARTERY OCCLUSION 5 0.0004
797 GASTROINTESTINAL PAIN 4 0.0004
798 HEART RATE INCREASED 36 0.0004
799 SWELLING 34 0.0004
800 GASTROOESOPHAGEAL REFLUX DISEASE 29 0.0004
801 SKIN DISORDER 12 0.0004
802 DEPRESSED MOOD 19 0.0004
803 HUNGER 5 0.0004
804 CONDITION AGGRAVATED 109 0.0004
805 MALAISE 157 0.0004
806 DISEASE RECURRENCE 17 0.0004
807 RASH PRURITIC 19 0.0004
808 CHOLECYSTECTOMY 4 0.0003
809 PRODUCT PHYSICAL ISSUE 7 0.0003
810 HYPERTHYROIDISM 5 0.0003
811 FLUID OVERLOAD 5 0.0003
812 DRUG INTOLERANCE 33 0.0003
813 COLD SWEAT 6 0.0003
814 ILLNESS 35 0.0003
815 COLON CANCER 5 0.0003
816 MACULAR DEGENERATION 4 0.0003
817 EYE DISORDER 11 0.0003
818 BLOOD PRESSURE FLUCTUATION 8 0.0003
819 BONE LOSS 5 0.0003
820 MENTAL IMPAIRMENT 8 0.0003
821 RETCHING 7 0.0003
822 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
823 LIMB DISCOMFORT 10 0.0003
824 AMNESIA 21 0.0003
825 CYST 4 0.0003
826 CHEST DISCOMFORT 33 0.0003
827 HEPATIC STEATOSIS 6 0.0003
828 OXYGEN SATURATION DECREASED 18 0.0003
829 HAEMATEMESIS 8 0.0003
830 TACHYCARDIA 28 0.0003
831 FEELING JITTERY 6 0.0003
832 SLEEP APNOEA SYNDROME 6 0.0003
833 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
834 LOWER LIMB FRACTURE 6 0.0003
835 GLAUCOMA 6 0.0003
836 TREATMENT NONCOMPLIANCE 17 0.0003
837 DYSGEUSIA 23 0.0003
838 LABORATORY TEST ABNORMAL 9 0.0003
839 OSTEONECROSIS 10 0.0003
840 RESPIRATORY DISORDER 9 0.0003
841 EAR INFECTION 8 0.0003
842 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
843 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
844 HEMIPARESIS 5 0.0003
845 INJURY ASSOCIATED WITH DEVICE 6 0.0003
846 SWELLING FACE 19 0.0003
847 BLOOD GLUCOSE DECREASED 14 0.0003
848 NERVOUS SYSTEM DISORDER 9 0.0003
849 NEURALGIA 7 0.0003
850 HEADACHE 180 0.0003
851 APHONIA 4 0.0003
852 DERMATITIS 6 0.0003
853 SPEECH DISORDER 15 0.0003
854 WOUND 8 0.0003
855 BLISTER 16 0.0003
856 FEELING ABNORMAL 68 0.0003
857 DIALYSIS 4 0.0003
858 COUGH 79 0.0003
859 DISTURBANCE IN ATTENTION 15 0.0003
860 TREMOR 46 0.0003
861 C-REACTIVE PROTEIN INCREASED 10 0.0003
862 APATHY 4 0.0003
863 MUSCULOSKELETAL STIFFNESS 24 0.0003
864 STAPHYLOCOCCAL INFECTION 9 0.0003
865 VIRAL INFECTION 9 0.0003
866 BRONCHITIS 20 0.0003
867 CONJUNCTIVITIS 5 0.0003
868 IMMUNODEFICIENCY 4 0.0003
869 APHASIA 8 0.0003
870 THERAPEUTIC RESPONSE DECREASED 16 0.0003
871 PRODUCT AVAILABILITY ISSUE 6 0.0003
872 SHOCK 6 0.0003
873 CHOLESTASIS 5 0.0003
874 PRODUCT PRESCRIBING ERROR 6 0.0003
875 OBESITY 4 0.0003
876 HEPATIC CANCER 6 0.0002
877 BLINDNESS 10 0.0002
878 INJECTION SITE MASS 9 0.0002
879 EYE SWELLING 9 0.0002
880 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
881 TOOTH LOSS 5 0.0002
882 LIP SWELLING 8 0.0002
883 SKIN DISCOLOURATION 11 0.0002
884 CATARACT 14 0.0002
885 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
886 SKIN ULCER 6 0.0002
887 EOSINOPHILIA 4 0.0002
888 TOOTH DISORDER 5 0.0002
889 DRY SKIN 30 0.0002
890 SWOLLEN TONGUE 7 0.0002
891 ORAL PAIN 5 0.0002
892 RASH 97 0.0002
893 END STAGE RENAL DISEASE 4 0.0002
894 HYPOTHYROIDISM 7 0.0002
895 INFLUENZA LIKE ILLNESS 18 0.0002
896 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
897 MOVEMENT DISORDER 7 0.0002
898 ABNORMAL DREAMS 6 0.0002
899 RHINORRHOEA 14 0.0002
900 INFLAMMATION 11 0.0002
901 HEPATIC CIRRHOSIS 4 0.0002
902 UNEVALUABLE EVENT 16 0.0002
903 VISION BLURRED 29 0.0002
904 HERNIA 4 0.0002
905 PSYCHOTIC DISORDER 6 0.0002
906 RENAL INJURY 6 0.0002
907 INJURY 14 0.0002
908 EXTRA DOSE ADMINISTERED 8 0.0002
909 FLUSHING 20 0.0002
910 LUNG NEOPLASM MALIGNANT 8 0.0002
911 PERITONITIS 4 0.0002
912 BONE DENSITY DECREASED 6 0.0002
913 DEAFNESS 5 0.0002
914 ARTHRITIS 15 0.0002
915 JOINT STIFFNESS 5 0.0002
916 NASOPHARYNGITIS 35 0.0002
917 HALLUCINATION, VISUAL 4 0.0002
918 DEPRESSION 43 0.0002
919 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 34 0.0002
920 VISUAL IMPAIRMENT 23 0.0002
921 THROAT TIGHTNESS 5 0.0002
922 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
923 IRRITABILITY 11 0.0002
924 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
925 PRODUCT USE ISSUE 34 0.0002
926 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
927 PANCREATIC CARCINOMA 5 0.0002
928 HALLUCINATION 13 0.0002
929 NERVOUSNESS 9 0.0002
930 DYSKINESIA 7 0.0002
931 BLADDER CANCER 10 0.0002
932 RASH ERYTHEMATOUS 8 0.0002
933 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
934 PANIC ATTACK 6 0.0002
935 ACCIDENTAL OVERDOSE 6 0.0002
936 DISCOMFORT 10 0.0002
937 AGITATION 12 0.0002
938 ABASIA 4 0.0002
939 PRURITUS 62 0.0002
940 EYE IRRITATION 9 0.0002
941 ERYTHEMA 32 0.0002
942 DIPLOPIA 4 0.0002
943 TINNITUS 7 0.0002
944 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
945 INTENTIONAL PRODUCT MISUSE 13 0.0001
946 ALOPECIA 29 0.0001
947 PALLOR 4 0.0001
948 ANXIETY 41 0.0001
949 RASH MACULAR 5 0.0001
950 SKIN EXFOLIATION 12 0.0001
951 OSTEOARTHRITIS 6 0.0001
952 HYPOACUSIS 6 0.0001
953 PRODUCT DOSE OMISSION 9 0.0001
954 NEEDLE ISSUE 4 0.0001
955 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
956 ANGIOEDEMA 6 0.0001
957 ECZEMA 7 0.0001
958 DRUG ADMINISTRATION ERROR 4 0.0001
959 SINUSITIS 13 0.0001
960 ARTHROPATHY 7 0.0001
961 DRUG DEPENDENCE 20 0.0001
962 LACTIC ACIDOSIS 4 0.0001
963 DYSPHONIA 7 0.0001
964 WITHDRAWAL SYNDROME 5 0.0001
965 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
966 DEVICE DISLOCATION 5 0.0001
967 THROAT IRRITATION 5 0.0001
968 ANAPHYLACTIC REACTION 6 0.0001
969 HYPERSENSITIVITY 20 0.0001
970 COMA 5 0.0001
971 COLORECTAL CANCER 5 0.0001
972 PRODUCT STORAGE ERROR 9 0.0001
973 NASAL CONGESTION 6 0.0001
974 URTICARIA 17 0.0001
975 ILL-DEFINED DISORDER 6 0.0001
976 SUICIDAL IDEATION 9 0.0001
977 UNDERDOSE 7 0.0001
978 INJECTION SITE PAIN 29 0.0001
979 MENTAL DISORDER 4 0.0001
980 MEDICATION ERROR 5 0.0001
981 EYE PAIN 5 0.0001
982 OROPHARYNGEAL PAIN 8 0.0001
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
984 MIGRAINE 8 0.0001
985 OVERDOSE 18 0.0001
986 NO ADVERSE EVENT 14 0.0001
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
988 INJECTION SITE HAEMORRHAGE 5 0.0001
989 BURNING SENSATION 4 0.0001
990 RHEUMATOID ARTHRITIS 6 0.0001
991 PRODUCT QUALITY ISSUE 7 0.0001
992 DRUG DOSE OMISSION 7 0.0000
993 EMOTIONAL DISTRESS 5 0.0000